Trademark Details For XEROTEST (Serial Number 79044487)

XEROTEST
  • Rank
    Global Trademark Influence Ranking
    10544
0
0
0
0
  • Active Office Actions0
  • Conflicts0
  • Infringement0
Basic Information
Serial Number  United States - USPTO 79044487
Registration Number -
MarkXEROTEST
Filing Date Sep-14-2007
Status
Abandoned   IR CANCELLED.. (402)
Attorney Name

Action Tags
  
  
  



  • Mark Literal Elements:
  • Color(s) Claimed:

005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

010Medical apparatus

U.S Class(es): 026, 039, 044




Correspondences

NameOFFICE MEDITERRANEEN DE
AddressBREVETS D'INVENTION ET DE MARQUES, 20 rue de la Liberté F-06000 NICE FRANCE

Prosecution History

  
  
  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Apr-13-2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED   DENAO
Apr-12-2018DEATH OF INTERNATIONAL REGISTRATION   DETHP
Sep-04-2009FINAL DECISION TRANSACTION PROCESSED BY IB   FINTP
Jul-24-2009FINAL DISPOSITION NOTICE SENT TO IB   FICSP
Jul-24-2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB   FICRP
Apr-16-2009NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB   OPNXP
Apr-02-2009NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB   OPNSP
Apr-02-2009NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB   OPNRP
Jul-24-2008ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND   MAB2O
Jul-24-2008ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE   ABN2O
Jan-24-2008REFUSAL PROCESSED BY IB  
  
RFNTP
Dec-27-2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB  
  
RFCSP
Dec-27-2007REFUSAL PROCESSED BY MPU  
  
RFRRP
Dec-27-2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW  
  
RFCRE
Dec-26-2007NON-FINAL ACTION WRITTEN
  
CNRTR
Dec-18-2007ASSIGNED TO EXAMINER   DOCKD
Nov-07-2007NEW APPLICATION ENTERED IN TRAM   NWAPI
Nov-06-2007LIMITATION OF GOODS/SERVICES FROM IB ENTERED   LIMSI
Nov-01-2007SN ASSIGNED FOR SECT 66A APPL FROM IB   REPRM